A groundbreaking research effort has leveraged Google's AlphaFold3 to develop a novel computer-designed peptide gel, significantly advancing the process of personalized drug testing for uterine cancer...
Renowned Harvard geneticist Dr. David Sinclair has recently generated significant discussion in the longevity field, predicting the availability of age-reversing pills within the next decade, potentia...
New research presented at the 2025 European Society for Medical Oncology (ESMO) Congress reveals that receiving a SARS-CoV-2 mRNA vaccine significantly improves survival for patients with non-small ce...
A new artificial intelligence model, DrugReflector, has demonstrated a significant leap in drug discovery, achieving up to 17 times better hit-finding than traditional random screening methods. Develo...
Philadelphia-based biotechnology company Precigenetics is spearheading a novel approach to precision medicine, focusing on real-time epigenetic dynamics to revolutionize drug discovery. The company ai...
Parmita Mishra, CEO of Precigenetics, recently articulated a critical perspective on the state of drug discovery, particularly in oncology, stating that it's "not just cancer but also the implications...
Investor Bill Tai recently announced a significant collaboration in the pharmaceutical sector, revealing that Color has partnered with AstraZeneca for AI-enhanced drug discovery. Tai, a known backer o...
A new study has revealed that COVID-19 mRNA vaccination significantly extends the lives of patients battling advanced lung and skin cancers when administered close to the start of immunotherapy. Resea...
Anthrogen Bio, a six-person team from Y Combinator's S24 cohort, has officially launched Odyssey, a 102 billion-parameter protein language model, marking a significant advancement in AI for biology. T...
Parmita Mishra, CEO of Precigenetics, recently sparked discussion on social media with a statement challenging conventional perceptions of scientific endeavor, advocating for a shift from rigid seriou...
A recent publication in the prestigious journal *Nature* is shedding new light on the revolutionary advancements in cellular reprogramming, driven by cutting-edge genomic technologies. The study under...
San Francisco – Anthrogen (YC S24) has announced the launch of Odyssey, a protein language model boasting over 102 billion parameters, making it the largest and most performant of its kind. Developed ...
Longevity science company NOVOS is making advanced wellness solutions "accessible and shoppable" through its e-commerce platform, which is powered by WordPress. The platform, located at novoslabs.com,...
Researchers at the ARC Institute have unveiled a groundbreaking genome-editing technology, "Bridge recombinases," capable of making megabase-scale DNA rearrangements in human cells without relying on ...
A groundbreaking gene therapy treatment has successfully slowed the progression of Huntington's disease by 75% in a recent clinical trial, offering unprecedented hope for patients with the fatal inher...
Dillan DiNardo, CEO of Delix Therapeutics, recently announced the development of MSD-001, a novel compound he describes as "psychedelic tofu" engineered to engage specific access mechanisms without in...
South San Francisco – Cradle Health, a pioneering startup co-founded by Chief Science Officer Hunter C Davis, has unveiled its ambitious mission to create a "biology pause button" through reversible c...
San Francisco-based Until Labs, a biotechnology company focused on reversible cryopreservation, recently announced a significant Series A funding round of $58 million. This latest investment brings th...
Peter Magic, founder of Janoshik Lab, a prominent peptide testing facility, has offered insights into peptide stability, handling, and testing methodologies, challenging common misconceptions within t...
**Stanford, CA** – The Arc Institute has announced a significant breakthrough in synthetic biology, successfully designing viable bacteriophage genomes using artificial intelligence. This pioneering e...
Teiko Bio, a company co-founded by Ramji Srinivasan, has announced the expansion of its blood specimen stabilization services to Australia, offering its proprietary TokuKit technology for clinical tri...
Parmita Mishra, Founder and CEO of Precigenetics, has drawn attention to a significant challenge in data infrastructure: the simultaneous need for "hot streaming" and "cold archive" storage for hypers...
Recent scientific consensus and ongoing research strongly indicate that mRNA vaccines do not cause cancer; instead, they represent a significant advancement in the prevention and treatment of various ...
San Francisco, CA – Retro Biosciences, a longevity biotechnology company backed by OpenAI CEO Sam Altman, is set to commence human clinical trials for its experimental drug, RTR242. The pill is design...
Biologist and Precigenetics CEO Parmita Mishra has expressed profound optimism regarding humanity's proximity to creating a "better reality" through scientific advancements, particularly in the realm ...
NEW HYDE PARK, N.Y. – SetPoint Medical, in collaboration with Northwell Health, has announced the U.S. Food and Drug Administration (FDA) approval of its SetPoint® System for the treatment of moderate...
San Francisco, CA – Medra, a pioneering AI robotics startup, officially launched its "Continuous Science Platform" on September 11, 2025, aiming to transform life science research through advanced lab...
Philadelphia, PA – Precigenetics, a biotechnology company founded in 2024, is pioneering a novel approach to drug discovery, focusing on real-time observation of epigenome interactions with potential...
A prominent network of ultra-wealthy investors, including PayPal co-founder Peter Thiel and OpenAI CEO Sam Altman, has collectively poured over $5 billion into the burgeoning longevity industry over t...
Berlin, Germany – ARLAN BIOTECH, a pioneering deeptech startup from Kazakhstan, recently achieved a significant milestone by securing second place at the Supernova Challenge during GITEX Europe 2025. ...
Palo Alto, California – The Arc Institute has announced the release of "State," its inaugural virtual cell model designed to predict how various cell types, including stem, cancer, and immune cells, r...
Recent findings and personal accounts are drawing attention to Intermittent Hypoxia Hyperoxia Therapy (IHHT), a method involving alternating periods of low and high oxygen exposure. Entrepreneur Bryan...
Lausanne, Switzerland – Two interns at Adaptyv Bio, a company co-founded by Julian Englert, have successfully developed a novel protein biosensor from scratch in just a few weeks, including wet lab va...
**AUSTIN, Texas** – Gameto, a clinical-stage biotechnology company co-founded by serial entrepreneur Martin Varsavsky, recently announced a $44 million Series C funding round, bringing its total capit...
A new clinical trial for Progeria, an ultra-rare genetic condition causing rapid aging, has received authorization from the U.S. Food and Drug Administration (FDA). This development marks a significan...
Gainesville, Florida – Researchers at the University of Florida have announced a significant advancement in cancer immunotherapy with the development of an experimental mRNA-based vaccine. This novel ...
Boston, MA – STAT, a leading publication covering biopharma, health, and life sciences, has announced a significant discount on its annual subscription for a broad range of professionals and students....
London, UK – Bio Protocol, a biotech financial platform, has unveiled a new governance proposal on ResearchHub to fund a pioneering study into psilocybin's neuroprotective role in stroke. The initiati...
Palo Alto, CA – Paul Graham, co-founder of Y Combinator, recently highlighted a significant trend within the startup accelerator's portfolio: multiple companies are developing cancer cures that are ne...
Recent research indicates that a single dose of psilocybin, the psychoactive compound found in certain mushrooms, can induce significant and sustained changes in brain function, leading to improvement...
Bio Protocol has announced the commencement of the Ignition Sale for Aubrai, its inaugural BioAgent project, beginning this Monday. The 24-hour fixed-price sale, hosted on the Bio launchpad, sets Aubr...
A significant new resource for artificial intelligence in drug discovery, DynaRepo, has been announced, providing an unprecedented collection of molecular dynamics (MD) simulation data. The repositor...
Leading epigenetics researcher Jacob Kimmel has outlined three key evolutionary complications that explain why natural selection has not optimized for extended human lifespans, despite the potential f...
**Boston, MA** – The pharmaceutical industry is increasingly looking to advanced preclinical models, such as organ chips, to mitigate the high failure rates and significant costs associated with drug ...
San Francisco, CA – Convoke, a company focused on developing AI tools for the biopharmaceutical industry, has successfully closed an $8.6 million seed financing round. The funding was led by prominent...
Silicon Valley-based company Orchid, founded by Noor Siddiqui, is at the forefront of a burgeoning field, offering comprehensive genetic screening for embryos to prospective parents. The company aims ...
A public discussion hosted by Interintellect, featuring political philosopher Adam Gjesdal and bioethicist Dr. Jonathan Anomaly, is set to delve into the burgeoning field of trait-based embryo selecti...
The escalating incidence of cancer with advancing age is a well-documented phenomenon, with rates climbing dramatically from young adulthood into senior years. This significant increase is primarily a...
Recent scientific advancements, particularly in gene editing, are bringing renewed hope for a potential cure for Progeria, a rare genetic disorder that causes rapid, premature aging in children. The N...
San Francisco, CA – Noor Siddiqui, CEO of biotech startup Orchid Health, has boldly declared that her company's advanced whole-genome embryo screening will become the "default way smart parents have b...
Cambridge, MA – Researchers at the Massachusetts Institute of Technology (MIT) have successfully designed novel antibiotics using artificial intelligence (AI) that show promise against two difficult-t...
UCLA researchers have developed a novel CAR-NKT cell therapy that demonstrated 100% efficacy in preclinical tests against ovarian cancer, including chemo-resistant tumors. The breakthrough, led by Dr....
Ruxandra Teslo, a prominent voice in science and innovation, recently highlighted a significant barrier to progress in the biotechnology sector: the lack of public access to regulatory filings. In a r...
Ruxandra Teslo, a prominent voice in the biotech sector, recently highlighted a significant challenge for emerging biotechnology companies: navigating the complex U.S. Food and Drug Administration (FD...
A translational scientist recently encountered a significant setback in a clinical trial, losing approximately 89% of critical flow cytometry specimens due to preservation issues. The incident, shared...
A recent grant application focusing on cellular rejuvenation, submitted by prominent biogerontologist João Pedro de Magalhães, received feedback that highlighted a significant ethical divide within th...
The U.S. Food and Drug Administration (FDA) has granted approval to SetPoint Medical's SetPoint System, a pioneering neuroimmune modulation device designed for the treatment of moderate-to-severe rheu...
Discussions surrounding embryo selection within academic and conference settings are predominantly focused on ethical challenges and inherent limitations, rather than perceived benefits or widespread ...
San Francisco-based biotech firm NewLimit, co-founded by Coinbase CEO Brian Armstrong, has recently raised $130 million in Series B funding. This significant investment aims to accelerate the company'...
A specific genetic mutation, known as CCR5-Δ32, renders some individuals resistant to common strains of HIV-1 by disabling a crucial immune cell receptor that the virus typically exploits for entry. ...
Menlo Park, California – Andreessen Horowitz (a16z) Bio + Health has partnered with pharmaceutical giant Eli Lilly and Company to establish a new $500 million venture capital fund. Named the Biotech E...
A growing body of scientific research is underscoring the profound influence of gut bacteria on metabolic syndrome, a cluster of conditions including diabetes and cardiovascular issues. Renowned scien...
Pearl Freier, President of Cambridge BioPartners, a strategic advisory firm in the biopharmaceutical and healthcare technology industries, recently voiced concerns regarding the U.S. Food and Drug Adm...
China is significantly accelerating its investment in university-level biotechnology, a trend observed to be gaining momentum partly due to recent funding difficulties experienced by the U.S. National...
**New York, NY** – The intricate connection between mitochondrial health and egg quality is gaining significant attention in the field of reproductive science, with experts highlighting its crucial ro...
Cambridge, MA, and Austin, TX – A recent tweet by Pearl Freier has ignited discussion regarding corporate governance within the biotech sector, specifically highlighting the dual board membership of R...
Vancouver, Canada – NewLimit, a biotechnology company focused on extending human healthspan, has announced a significant advancement in its AI-driven epigenetic reprogramming research, demonstrating a...
Researchers at the National Cancer Center in Tokyo have identified a novel gut bacterium, Hominenteromicrobium strain YB328, that significantly enhances the effectiveness of PD-1 blockade immunotherap...
University of Pennsylvania researchers have achieved a significant breakthrough in the fight against antibiotic resistance, utilizing an artificial intelligence (AI) system named APEX to identify and ...
Researchers have introduced a novel scientific model, dubbed "Cell Annealing," designed to deepen the understanding of cellular aging and rejuvenation processes. Announced by "Dr Singularity" on socia...
Recent high-resolution video footage captured by cell biologist Alex Ritter of RitterLab vividly demonstrates a killer T cell of the immune system actively destroying a monstrous ovarian cancer cell. ...
A recent social media post by "Dr. Shelby" has spotlighted ten biotechnology companies operating at the forefront of scientific innovation, often navigating complex ethical and legal landscapes. The t...
Centivax, a biotechnology firm focused on durable and universal vaccines, has successfully closed an oversubscribed $45 million Series A funding round. The investment was led by Steve Jurvetson's Futu...
The efficacy of plasmapheresis in reversing human biological aging is currently yielding contradictory results in recent clinical trials. While some research indicates a potential acceleration of agin...
QuantumBio Therapeutics, a pioneering firm at the intersection of quantum mechanics and biological research, has announced the successful closure of a $750 million Series D funding round. The signific...
Recent discussions, notably highlighted by physicist and Genomic Prediction co-founder Steve Hsu, underscore the burgeoning market for polygenic embryo screening (PES) within in vitro fertilization (I...
Dr. George Church, a pioneering molecular engineer and Professor of Genetics at Harvard Medical School, has articulated a vision where biotechnology could enable humans to reach "escape velocity" from...
**Seoul, South Korea** – A novel deep learning model, Cancer Drug Response Profile scan (CDRscan), has demonstrated remarkable accuracy, achieving an R² value exceeding 0.84 and an AUROC over 0.98, in...
